Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALX Oncology Holdings

0.5025
-0.0278-5.24%
Volume:300.50K
Turnover:152.05K
Market Cap:26.83M
PE:-0.19
High:0.5399
Open:0.5275
Low:0.4902
Close:0.5303
Loading ...

ALX Oncology Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Mar

ALX Oncology Holdings Q4 2024 Adj EPS $(0.44) Beats $(0.67) Estimate

Benzinga
·
07 Mar

BRIEF-ALX Oncology Q4 Basic EPS USD -0.55

Reuters
·
07 Mar

ALX Oncology Holdings Inc: Expected to Extend Cash Runway Into Q4 2026

THOMSON REUTERS
·
07 Mar

ALX Oncology Q4 Basic EPS USD -0.55

THOMSON REUTERS
·
07 Mar

ALX Oncology Q4 Income From Operations USD -30.613 Million

THOMSON REUTERS
·
07 Mar

Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and Elicio Therapeutics (ELTX)

TIPRANKS
·
07 Mar

ALX Oncology Holdings Inc : Jefferies Raises to Buy From Hold; Raises Target Price to $3 From $2

THOMSON REUTERS
·
06 Mar

Jefferies Upgrades ALX Oncology to Buy From Hold, Adjusts Price Target to $3 From $2

MT Newswires Live
·
06 Mar

ALX Oncology Raised to Buy From Hold by Jefferies

Dow Jones
·
06 Mar

ALX Oncology Holdings: Undervalued with Promising Catalysts and Growth Opportunities

TIPRANKS
·
06 Mar

BRIEF-Alx Oncology Holdings Inc To Reduce Workforce By 30%

Reuters
·
06 Mar

ALX Oncology Holdings Inc - Expects $2.2 Million in Severance Expenses

THOMSON REUTERS
·
06 Mar

ALX Oncology Holdings Inc - Workforce Reduction Expected to Complete by End of May 2025

THOMSON REUTERS
·
06 Mar

ALX Oncology to Cut Workforce by 30% to Support New Clinical Initiatives

MT Newswires Live
·
05 Mar

ALX Oncology will highlight progress across its clinical pipeline

TIPRANKS
·
05 Mar

ALX Oncology Holdings Inc expected to post a loss of 67 cents a share - Earnings Preview

Reuters
·
04 Mar

February 2025 US Penny Stocks With Promising Prospects

Simply Wall St.
·
19 Feb

UBS Cuts Price Target on ALX Oncology Holdings to $2.20 From $4, Keeps Buy Rating

MT Newswires Live
·
27 Jan

ALX Oncology Holdings Inc : UBS Cuts Target Price to $2.2 From $4

THOMSON REUTERS
·
27 Jan